This is a prospective, randomized (1:1), pilot study enrolling 200 patients with symptomatic atrial fibrillation or atrial tachycardia (AF/AT) recurrence requiring repeat ablation following a single prior PVI procedure for AF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
Cardioangiologisches Centrum Bethanien, Frankfurt am Main, 60431
Frankfurt am Main, Hesse, Germany
RECRUITINGPrimary Endpoint
Complete re-pulmonary vein isolation (re-PVI), Bidirectional conduction block across linear lesions, Complete substrate elimination (defined as: voltage abatement and/or loss of capture).
Time frame: Within the study duration of 1 Year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.